Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|April 10, 2007
Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillationFrank Lezoualc'h, Klaudia Steplewski, Laura Sartiani, et al.Medecine Sciences : M/S|September 26, 2017
[Cardiac lymphatic system]Barbara Garmy-Susini, Nathalie Pizzinat, Nicole Villeneuve, et al.European Journal of Pharmacology|October 3, 2003
Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECAHelen L Maddock, Neil M Gardner, Nassirah Khandoudi, et al.Peptides|February 26, 2008
Behavioral actions of urotensin-IIJean-Claude do Rego, Jérôme Leprince, Elizabeth Scalbert, et al.British Journal of Pharmacology|August 2, 2003
Melatonin inhibits nitrate tolerance in isolated coronary arteriesStephen T O'Rourke, Hana Hammad, Philippe Delagrange, et al.Diabetes|April 30, 2002
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injuryNassirah Khandoudi, Philippe Delerive, Isabelle Berrebi-Bertrand, et al.British Journal of Pharmacology|January 14, 2004
Impact of treatment with melatonin on cerebral circulation in old ratsFrançois Dupuis, Olivier Régrigny, Jeffrey Atkinson, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 10, 2003
Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885Cédric Logé, Valérie Wallez, Elizabeth Scalbert, et al.Nature Reviews. Drug Discovery|April 2, 2014
Integrative knowledge management to enhance pharmaceutical R&DMaria Marti-Solano, Ewan Birney, Antoine Bril, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 29, 2004
Design and synthesis of indole and tetrahydroisoquinoline hydantoin derivatives as human chymase inhibitorsDavid Alagille, Bruno Pfeiffer, Elizabeth Scalbert, et al.Pageof 4